myelocytic


Also found in: Dictionary, Thesaurus, Encyclopedia.

my·e·lo·cyt·ic

(mī'ĕ-lō-sit'ik),
Pertaining to or characterized by myelocytes.
Farlex Partner Medical Dictionary © Farlex 2012

my·e·lo·cyt·ic

(mī'ĕ-lō-sit'ik)
Pertaining to or characterized by myelocytes.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

myelocytic

(mī″ĕl-ō-sĭt′ĭk)
Characterized by presence of, or pert. to, myelocytes.
Medical Dictionary, © 2009 Farlex and Partners
References in periodicals archive ?
The biopsy obtained from the skin lesions before and testicular biopsy were found to be compatible with acute myelocytic leukemia (21).
Table-I: Lymphocytic and Myelocytic infiltration in Pre-neoplastic (DCIS), cancer (IDC) and control tissues.
These compounds have application in treatment of numerous diseases like chronic myelocytic leukemia [8].
Effective chemotherapy of acute myelocytic leukemia occurring after alkylating agent or radiation therapy for prior malignancy.
Baccharin (3-prenyl-4-(2,3-dihydrocinnamoyloxy) cinnamic acid) and Drupanin (3-prenyl-4 hydroxycinnamic acid) possess tumoricidal activity and induce apoptosis against the myelocytic leukemia cell line HL60 (Akao et al., 2003).
Widespread eruptive dermal and atypical melanocytic nevi in association with chronic myelocytic leukemia: a case report and review of the literature.
It can be found in response to an infection (such as acquired immune deficiency syndrome), inflammation, and rarely in myeloproliferative disorders (i.e., chronic myelocytic leukemia).
(4) MJ activated the MAPK pathway in the human myelocytic leukemia cell line HL-60, but the outcome of this event was cell differentiation rather than apoptosis [41]; the differentiation effect was inhibited by PD98059, a MEK1 inhibitor, confirming the involvement of MAPK/ERK pathway in this MJ-mediate activity [41].
(10,11) This type of mutation has not been found in acute lymphoblastic leukemia (ALL), chronic myelocytic leukemia (CML), blast crisis CML, or in normal individuals.
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a Cancer and Leukemia Group B study Blooel 1982;60:454-462.